203 related articles for article (PubMed ID: 11798949)
1. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
2. [Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell].
Yuan Y; Xu DL; Liu YL; Jia MY
Sheng Li Xue Bao; 1999 Jun; 51(3):285-90. PubMed ID: 11498990
[TBL] [Abstract][Full Text] [Related]
3. [Different expressions of cyclins and cyclin dependent kinase inhibitor P27 in vascular smooth muscle cells and cardiac myocytes caused by angiotensin II and PDGF stimulation].
Xu D; Yuan Y; Liu Y
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):657-60. PubMed ID: 11715452
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of cyclin-dependent kinase inhibitors by mitogen-activated protein kinase in angiotensin II-stimulated vascular smooth muscle cell hypertrophy].
Liu Y; Xu DL; Wang MH; Ouyang P; Lai WY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):114-6. PubMed ID: 12390801
[TBL] [Abstract][Full Text] [Related]
5. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
Rao GN
Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305
[TBL] [Abstract][Full Text] [Related]
7. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ
J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417
[TBL] [Abstract][Full Text] [Related]
8. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
[TBL] [Abstract][Full Text] [Related]
9. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Hupfeld CJ; Weiss RH
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.
Servant MJ; Coulombe P; Turgeon B; Meloche S
J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779
[TBL] [Abstract][Full Text] [Related]
11. Effects of lovastatin on expression of cell cycle regulatory proteins in vascular smooth muscle cells.
Oda H; Kasiske BL; O'Donnell MP; Keane WF
Kidney Int Suppl; 1999 Jul; 71():S202-5. PubMed ID: 10412776
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.
Mueller C; Baudler S; Welzel H; Böhm M; Nickenig G
Circulation; 2002 May; 105(20):2423-8. PubMed ID: 12021231
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
14. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2003 Apr; 63(4):1374-81. PubMed ID: 12631353
[TBL] [Abstract][Full Text] [Related]
15. 2,3,4',5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle.
Xu XL; Huang YJ; Wang YQ; Chen XF; Zhang W
Clin Exp Pharmacol Physiol; 2011 May; 38(5):307-13. PubMed ID: 21348889
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
17. Proprotein convertase PC5 regulation by PDGF-BB involves PI3-kinase/p70(s6)-kinase activation in vascular smooth muscle cells.
Stawowy P; Blaschke F; Kilimnik A; Goetze S; Kallisch H; Chrétien M; Marcinkiewicz M; Fleck E; Graf K
Hypertension; 2002 Feb; 39(2 Pt 2):399-404. PubMed ID: 11882580
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy.
Okamoto K; Kato S; Arima N; Fujii T; Morimatsu M; Imaizumi T
Hypertens Res; 2004 Apr; 27(4):283-91. PubMed ID: 15127886
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf.
Liao DF; Duff JL; Daum G; Pelech SL; Berk BC
Circ Res; 1996 Nov; 79(5):1007-14. PubMed ID: 8888693
[TBL] [Abstract][Full Text] [Related]
20. Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1.
Yu HZ; Xie LD; Zhu PL; Xu CS; Wang HJ
Mol Cell Biochem; 2012 Jan; 360(1-2):363-71. PubMed ID: 21959973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
